Funding Opportunities

NIH Funding Opportunities

Notice of Extension of the Expiration Date and Change in Agency Contacts for PA-15-109 "Supplements to Advance Research (STAR) from Projects to Programs (Admin Supplement)"
Notice NOT-AR-17-016 from the NIH Guide for Grants and Contracts
Wed, 15 Feb 2017 10:49:47 EST

Notice of Change of Key Dates for PAR-17-125 "Perception and Cognition Research to Inform Cancer Image Interpretation (R01)"
Notice NOT-CA-17-031 from the NIH Guide for Grants and Contracts
Wed, 15 Feb 2017 09:59:57 EST

Notice of Change of Key Dates for PAR-17-124 "Perception and Cognition Research to Inform Cancer Image Interpretation (R21)"
Notice NOT-CA-17-032 from the NIH Guide for Grants and Contracts
Wed, 15 Feb 2017 11:13:11 EST

FDA Will Not Be Receiving Applications in 2017 for the Collaborating Centers of Excellence in Regulatory Science and Innovation Funding Opportunity Announcement
Notice NOT-FD-17-002 from the NIH Guide for Grants and Contracts
Thu, 16 Feb 2017 10:42:57 EST

NICHD Call for Administrative Supplements to PA-16-287 in High Priority MPID and HIV/AIDS OAR Areas
Notice NOT-HD-17-002 from the NIH Guide for Grants and Contracts
Tue, 14 Feb 2017 02:04:19 EST

NICHD Interest in Administrative Supplements for Enhancing Multipurpose Technology for the Prevention of Pregnancy and HIV
Notice NOT-HD-17-003 from the NIH Guide for Grants and Contracts
Tue, 14 Feb 2017 12:29:50 EST

Rescinding Notice For NOT-HL-16-329: Administrative Supplements to Enhance HIV-related Heart, Lung, Blood, and Sleep Research
Notice NOT-HL-17-487 from the NIH Guide for Grants and Contracts
Tue, 14 Feb 2017 12:38:09 EST

Impact of Washington, DC Area Federal Office Operating Status on AHRQ Grant Application Due Dates
Notice NOT-HS-17-007 from the NIH Guide for Grants and Contracts
Wed, 15 Feb 2017 10:37:32 EST

Notice of Informational Webinar for Applicants of NIMH Institutional Training Grants (T32)
Notice NOT-MH-17-013 from the NIH Guide for Grants and Contracts
Thu, 16 Feb 2017 10:12:26 EST

Update on Clinical Trial Funding Opportunity Announcement Policy
Notice NOT-OD-17-043 from the NIH Guide for Grants and Contracts
Fri, 17 Feb 2017 10:59:20 EST

Notice of NCATS Participation in PA-17-090 "NLM Administrative Supplements for Informationist Services in NIH-funded Research Projects (Admin Supp)"
Notice NOT-TR-17-009 from the NIH Guide for Grants and Contracts
Mon, 13 Feb 2017 02:13:30 EST

Oral HIV Vaccination: Strategy Synergistic to Systemic Vaccination (R01)
Funding Opportunity RFA-DE-18-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages hypothesis driven basic, translational and pre-clinical science research to develop novel approaches for prophylactic oral mucosal vaccine that will be synergistic with systemic vaccination for protection against HIV infection.
Mon, 13 Feb 2017 10:19:38 EST

Environmental influences on Placental Origins of Development (ePOD) (R01)
Funding Opportunity RFA-ES-17-005 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate multidisciplinary research projects from the scientific community that use a combination of animal/cell models and non-invasive human placenta tissues or biomarkers to investigate how early life exposures affect placental growth, development, and function, and the subsequent health of the offspring.
Wed, 15 Feb 2017 11:07:53 EST

NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01)
Funding Opportunity RFA-MH-18-200 from the NIH Guide for Grants and Contracts. The NIMH Biobehavioral Research Awards for Innovative New Scientists (BRAINS) award is intended to support the research and research career advancement of outstanding, exceptionally productive scientists who are in the early, formative stages of their careers and who plan to make a long term career commitment to research in specific mission areas of the NIMH. This award seeks to assist these individuals in launching an innovative clinical, translational, basic or services research program that holds the potential to profoundly transform the understanding, diagnosis, treatment, or prevention of mental disorders. The NIMH BRAINS program will focus on the research priorities and gap areas identified in the NIMH Strategic Plan and the Research Domain Criteria (RDoC) project.
Fri, 17 Feb 2017 11:51:17 EST

Research Education Program Grants for CryoEM Curriculum Development (R25)
Funding Opportunity RFA-RM-17-004 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this Common Fund R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Curriculum or Methods Development in cryoelectron microscopy (cryoEM) for structural biology research.
Mon, 13 Feb 2017 01:44:47 EST

Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02)
Funding Opportunity RFA-TR-17-001 from the NIH Guide for Grants and Contracts. The NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules [New Therapeutic Uses (NTU)] program is designed to develop partnerships between pharmaceutical companies and the biomedical research community to advance therapeutics development. This innovative program matches researchers with a selection of pharmaceutical industry assets to test ideas for new therapeutic uses with the ultimate goal of identifying promising new treatments for patients. The program was designed to enable efficient 3-way drug repositioning partnerships between academic, government, and pharmaceutical partners.
Wed, 15 Feb 2017 02:47:45 EST

Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (UG3/UH3)
Funding Opportunity RFA-TR-17-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications that support testing new therapeutic uses for experimental drugs or biologics (Assets) across a broad range of human diseases. This innovative program allows investigators to propose new therapeutic uses for Assets from pharmaceutical company partners. Strong applications will include scientific evidence that modulation of an Assets target should have a positive impact on the disease/condition. An X02 pre-application is the first step in the application process for RFA-TR-17-002 and RFA-TR-17-003. X02 pre-applications will be evaluated by outside experts. Investigators whose X02 pre-applications are judged to be the most meritorious and relevant to NIH program priorities will be notified of the opportunity to submit a UG3/UH3 application under this FOA. The initial UG3 award will support the development of rigorous, pre-clinical efficacy studies and clinical trial planning activities. If UG3 pre-clinical milestones are met, the UH3 award may be made to support clinical trials.
Wed, 15 Feb 2017 02:47:36 EST

Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses for Existing Molecules (UG3/UH3)
Funding Opportunity RFA-TR-17-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications that support testing new therapeutic uses for experimental drugs or biologics (Assets) across a broad range of human diseases unique to pediatric populations. This innovative program allows investigators to propose new therapeutic uses for Assets from pharmaceutical company partners. Strong applications will include scientific evidence that modulation of an Assets target will have a positive impact on the disease/condition. An X02 pre-application is the first step in the application process for RFA-TR-17-002 and RFA-TR-17-003. X02 pre-applications will be evaluated by outside experts. Investigators whose X02 pre-applications are judged to be the most meritorious and relevant to NIH program priorities will be notified of the opportunity to submit a UG3/UH3 application under this FOA. The initial UG3 award will support the development of rigorous, pre-clinical efficacy studies and clinical trial planning activities. If UG3 pre-clinical milestones are met, the UH3 award may be made to support clinical trials.
Wed, 15 Feb 2017 02:47:41 EST

NCATS Pilot Program for Collaborative Drug Discovery Research using Bioprinted Skin Tissue (U18)
Funding Opportunity RFA-TR-17-007 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to enable the development of 3D-bioprinted tissue models for drug discovery, including efficacy studies and toxicology research through a collaborative arrangement between the 3-D Bioprinting Program at the National Center for Advancing Translational Sciences (NCATS) and extramural scientists. NCATS intramural scientists will provide expertise for 3-D bioprinting, assay development and drug screening stages of the projects. Extramural investigators will provide appropriate cell resources, disease expertise and model validation in collaboration with NCATS to perform drug screening of bioprinted materials. The research application will involve 3-D bioprinting in a screening format of patient-derived cells supplied by the extramural investigators, characterization and validation of bioprinted materials by NCATS investigators and extramural collaborators, and screening of appropriate molecular libraries.
Mon, 13 Feb 2017 02:01:24 EST

Aging Biology Research to Address Health Disparities (Admin Supp)
Funding Opportunity PA-17-164 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) announces the availability of administrative supplements to support aging biology research that addresses disparities in health.
Mon, 13 Feb 2017 10:37:31 EST

Research to Support the Reduction and Elimination of Mental Health Disparities (Admin Supp)
Funding Opportunity PA-17-165 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support Administrative Supplements to active NIMH grants to foster research across the NIMH Strategic Objectives that target the reduction and elimination of mental health disparities by race and ethnicity, geography, and socioeconomic status in the United States. This initiative aims to generate research within the scientific scope of the parent grant that identifies mechanisms underlying disparities or differences in mental health status and/or enhances optimal delivery of mental health interventions among diverse groups.
Mon, 13 Feb 2017 11:59:40 EST

Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34)
Funding Opportunity PA-17-166 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention or treatment. For the purposes of this FOA, intervention is defined to include behavioral, social, or structural approaches, as well as combination biomedical and behavioral, social, or structural approaches that prevent acquisition and transmission of HIV infection, or improve clinical outcomes for persons who are HIV infected, or both.
Mon, 13 Feb 2017 12:07:33 EST

Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01)
Funding Opportunity PAR-17-163 from the NIH Guide for Grants and Contracts. Patients with many disabilities report problems sleeping, but specific sleep disorders are often not diagnosed. Because sleep affects many physiological and behavioral parameters--depression, anxiety, pain, cancer, cardiovascular changes, immune function-- sleep disorders should be diagnosed and appropriately treated to maximize benefit of rehabilitation. Research is needed on ways to best approach this complexity in the context of medical rehabilitation for a primary, non-sleep disorder.
Mon, 13 Feb 2017 10:11:43 EST

Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)
Funding Opportunity PAR-17-167 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is intended to support clinical trials conducting preliminary evaluation of the safety and efficacy of imaging agents, as well as an assessment of imaging systems, image processing, image-guided planning and/or execution therapy, contrast kinetic modeling, 3-D reconstruction and other quantitative tools. As many such preliminary evaluations are early in development, this FOA will provide investigators with support for pilot (Phase I and II) cancer imaging clinical trials, including patient monitoring and laboratory studies. This FOA supports novel uses of known/standard clinical imaging agents and methods as well as the evaluation of new agents, systems, or methods. The imaging and image-guided intervention (IGI) investigations, if proven successful in these early clinical trials, can then be validated in larger studies through competitive R01 mechanisms, or through clinical trials in the Specialized Programs of Research Excellence (SPOREs), Cancer Centers and/or the NCI's National Clinical Trials Network.
Tue, 14 Feb 2017 02:27:11 EST

Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50)
Funding Opportunity PAR-17-168 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers working at different levels of analysis and employing integrative, novel, and creative experimental approaches to address high-risk, high-impact questions in basic neuroscience research, or in translational research with the primary objectives of: (a) advancing the state of the science in basic brain and behavior research that will uncover and dissect the underlying mechanisms that will ultimately provide the foundation for understanding mental disorders; (b) supporting the integration and translation of basic and clinical neuroscience research on severe mental illnesses; and/or (c) advancing our understanding of the neurobehavioral developmental mechanisms and trajectories of psychopathology that begin in childhood and adolescence. The Conte Centers program is intended to support interdisciplinary basic neuroscience or translational research demonstrating an extraordinary level of synergy, integration, and potential for advancing the state of the field. This program is intended only for projects that could not be achieved using other, more standard grant mechanisms. The Conte Centers program also provides an opportunity to establish interdisciplinary basic neuroscience or translational research experiences for students and post doctorates.
Fri, 17 Feb 2017 11:35:14 EST